Xinyinyuan launches brain-computer interface services for brain health management and pushes forward its financing process.
On November 7, 2026, during the 9th China International Import Expo, the themed conference "Comprehensively Advancing the Construction of a Healthy China: Empowering Healthy Aging with Digital Intelligence" was held at the National Exhibition and Convention Center (Shanghai). Cui Xinglong, President of Beijing NeuroDeep Intelligent Research Institute and Doctor of Computational and Neural Systems, delivered a keynote speech at the conference focusing on "AI and Brain-Computer Interface Empowering the Brain Health Ecosystem for Healthy Aging". This is one of the few public appearances of the enterprise founded in April 2026; its main entity, Beijing NeuroDeep Intelligent Technology Co., Ltd., is pushing forward a new round of financing.
Brain Health Data: Stuck at "Single Measurement"
Brain health is a field with real and expanding demand. At the same forum, data cited by Wang Peian, Chairman of the Academic Committee of the Academy of Health and Population Development Strategy, shows that there are more than 45 million disabled and demented elderly people in China, and the gap in elderly care workers exceeds 5 million; sleep disorders, children's concentration problems, emotion and fatigue management are also common troubles covering all groups of people.
However, there has always been a breakpoint in the quantification of brain health. Clinical electroencephalogram examinations rely on hospital-grade equipment, which takes tens of minutes for a single measurement and only obtains a "snapshot" at a certain point in time. For many years, consumer-grade wearable devices have been focused on peripheral physiological indicators such as heart rate and blood oxygen, and there has never been a mature daily entry for long-term continuous collection of EEG signals. NeuroDeep chooses to cut in from this point. According to the project information disclosed on 36Kr Venture Capital Platform, the company is committed to building an independent and controllable brain neural coding and decoding system, positioning itself as a brain intelligence infrastructure connecting the human brain, artificial intelligence and smart devices, with products covering four major scenarios: sleep improvement management, children's concentration improvement, brain health of the middle-aged and elderly, and adult emotion/fatigue/sports management.
Taking the "Neural Data Entry" with Concha Auriculae Collection and Transformer Algorithm
In terms of technical path, NeuroDeep has disclosed two core capabilities. The first is the auricular concha EEG collection technology: the electrode is hidden in the wearing form of the auricle structure, which is claimed to realize a neural data entry with "hidden wearing, long-term continuity and consumer-grade form", bringing EEG collection from hospital scenarios into daily life. The second is the self-developed algorithm EEG-TransNet™. According to the project introduction, this is an original algorithm that introduces the Transformer architecture into EEG signal modeling, with a classification accuracy of 93.3%.
It should be noted that the 93.3% accuracy data is disclosed by the project party itself, and no third-party verification in the real wearing environment and large clinical samples has been seen in public channels. At the same forum, You Mao, Deputy Director of the National Health Development Research Center of the National Health Commission, said in his concluding speech that "the independent and controllable brain coding and decoding platform and the idea of taking the family as the entry point and providing continuous data services for multiple generations of people have practical significance" — this judgment is in the same direction as NeuroDeep's product idea, and also defines the premise that this direction is considered worthy of investment.
Hardware Entry Plus Service Core
In terms of business model, NeuroDeep adopts the path of "hardware entry + service core": it completes the acquisition of continuous EEG data through consumer-grade wearable devices, and then forms sustainable value relying on data services. The industrial and commercial registration information shows that in addition to artificial intelligence algorithm and software development, and intelligent robot R&D, the company's business scope also includes the sales of Class I and Class II medical devices, as well as the operation of Class III medical devices that require permission, which reserves qualification space for it to move from consumer-grade health management to medical-grade applications.
Another Technology Implementation of a Serial Entrepreneur
Cui Xinglong's experience forms the technical background of this company. According to public information, he once engaged in cross-language search and semantic conversion research at Google Research USA, and won the "Top 10 Young Technology Pioneers Award" in Silicon Valley in 2005; since 2008, he has successively served as Vice President of Product and Technology of Sina Leju, Vice President and Chief Technology Officer of E-House China Group; he founded the fintech platform Qianyi in 2015; he founded Fermat Artificial Intelligence in 2017, trying to apply artificial intelligence and brain neuroscience to commercial scenarios; later he served as Co-President of Yuanzhi Technology Group and Executive Dean of Yuanzhi AI Intelligent Research Institute, and was selected into the "WIA Top 30 Global Scientific Entrepreneurs" in 2021. The brain region scale modeling practice during the Fermat Artificial Intelligence period is regarded as the pre-accumulation of NeuroDeep's technical route.
Industrial and commercial information shows that Beijing NeuroDeep Intelligent Technology Co., Ltd. was established on April 9, 2026, with a registered capital of 20 million yuan. Its registered address is located in Beijing Economic and Technological Development Zone. Cui Xinglong, the legal representative, holds 93% of the shares, and the other natural person shareholder Chen Yusen holds the remaining shares. In April 2026, the company completed the seed round financing, and is currently pushing forward a new round of financing.
The real situation is also worth recording: about 7 months after its establishment, no records of patents, trademarks, software copyright registrations or product releases have been found in public channels, and the actual performance of EEG-TransNet™ also needs to be tested in the real wearing environment. For a company starting with "data entry", whether it can produce mass-producible equipment and form a sustainably accumulated data scale will determine whether this set of development narratives can be fulfilled.